HELICOBACTER PYLORI FIRST-LINE TREATMENT WITH CLARITHROMYCIN AND METRONIDAZOLE IN PATIENTS ALLERGIC TO PENICILLIN: IS IT AN ACCEPTABLE OPTION?

被引：0
|
作者：
Gisbert, J. P. [2 ,3 ]
Perez-Aisa, A. [1 ]
Castro-Fernandez, M. [5 ]
Barrio, J. [4 ]
Rodrigo, L. [6 ]
Cosme, A. [7 ]
Gisbert, J. L. [2 ,3 ]
Marcos, S. [2 ,3 ]
机构：
[1] Agencia Sanitaria Costa del Sol, Malaga, Spain
[2] CIBEREHD, Madrid, Spain
[3] La Princesa Univ Hosp, Madrid, Spain
[4] Hosp Rio Hortega, Valladolid, Spain
[5] Hosp Valme, Seville, Spain
[6] Univ Oviedo, Hosp Cent Asturias, E-33080 Oviedo, Spain
[7] Hosp Donostia, San Sebastian, Spain
来源：
HELICOBACTER | 2012年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：102 / 103
页数：2
相关论文
共 50 条
  • [21] Vonoprazan improves the efficacy of Helicobacter pylori eradication therapy with a regimen consisting of clarithromycin and metronidazole in patients allergic to penicillin
    Ono, Shoko
    Kato, Mototsugu
    Nakagawa, Soichi
    Mabe, Katsuhiro
    Sakamoto, Naoya
    [J]. HELICOBACTER, 2017, 22 (03)
  • [22] The effect of Helicobacter pylori retreatment with ranitidine bismuth citrate, clarithromycin, and metronidazole depends on the first-line therapy
    Farup, PG
    Lange, OJ
    Tholfsen, J
    Hoeg, V
    Wetterhus, S
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2002, 35 (05) : 379 - 382
  • [23] Clarithromycin Versus Metronidazole as First-line Helicobacter pylori Eradication A Multicenter, Prospective, Randomized Controlled Study in Japan
    Nishizawa, Toshihiro
    Maekawa, Takama
    Watanabe, Noriko
    Harada, Naohiko
    Hosoda, Yasuo
    Yoshinaga, Masahiro
    Yoshio, Toshiyuki
    Ohta, Hajime
    Inoue, Syuuji
    Toyokawa, Tatsuya
    Yamashita, Haruhiro
    Saito, Hiroki
    Kuwai, Toshio
    Katayama, Shunsuke
    Masuda, Eiji
    Miyabayashi, Hideharu
    Kimura, Toshio
    Nishizawa, Yuko
    Takahashi, Masahiko
    Suzuki, Hidekazu
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2015, 49 (06) : 468 - 471
  • [24] High eradication rates of Helicobacter pylori infection with first and second line combination of esomeprazole, tetracycline and metronidazole in patients allergic to penicillin
    Rodriguez-Torres, M
    Salgado-Mercado, R
    Lopez-Torres, A
    Aponte-Rivera, E
    Marxuach-Cuetara, A
    Rodriguez-Orengo, JF
    Fernandez-Carbia, A
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S43 - S43
  • [25] New regimens as first-line eradication therapy for Helicobacter pylori infection in patients allergic to penicillin: A randomized controlled trial
    Zhang, Yuxin
    Suo, Baojun
    Tian, Xueli
    Zhang, Hua
    Lu, Haoping
    Yao, Xingyu
    Li, Cailing
    Ren, Xinlu
    Zhou, Liya
    Song, Zhiqiang
    [J]. HELICOBACTER, 2023, 28 (02)
  • [26] A Vonoprazan, Clarithromycin, and Metronidazole Regimen as Helicobacter pylori Eradication Therapy for Patients with Penicillin Allergy in Light of Clarithromycin Resistance
    Adachi, Kazunori
    Kato, Shunsuke
    Koshino, Akira
    Nagao, Kazuhiro
    Sugiyama, Tomoya
    Yoshimine, Takashi
    Yamaguchi, Yoshiharu
    Izawa, Shinya
    Ohashi, Wataru
    Ebi, Masahide
    Funaki, Yasushi
    Ogasawara, Naotaka
    Sasaki, Makoto
    Kasugai, Kunio
    [J]. INTERNAL MEDICINE, 2023, 62 (16) : 2301 - 2306
  • [27] Update on the first-line treatment of Helicobacter pylori infection in areas with high and low clarithromycin resistances
    Shih, Chih-An
    Shie, Chang-Bih
    Hsu, Ping-, I
    [J]. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
  • [28] Comparative Study of Clarithromycin- versus Metronidazole-Based Triple Therapy as First-Line Eradication for Helicobacter pylori
    Adachi, Teppei
    Matsui, Shigenaga
    Watanabe, Tomohiro
    Okamoto, Kazuki
    Okamoto, Ayana
    Kono, Masashi
    Yamada, Mitsunari
    Nagai, Tomoyuki
    Komeda, Yoriaki
    Minaga, Kosuke
    Kamata, Ken
    Yamao, Kentaro
    Takenaka, Mamoru
    Asakuma, Yutaka
    Sakurai, Toshiharu
    Nishida, Naoshi
    Kashida, Hiroshi
    Kudo, Masatoshi
    [J]. ONCOLOGY, 2017, 93 : 15 - 19
  • [29] The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori
    Uygun, A.
    Kadayifci, A.
    Safali, M.
    Ilgan, S.
    Bagci, S.
    [J]. HELICOBACTER, 2007, 12 (04) : 430 - 430
  • [30] The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori
    Uygun, Ahmet
    Kadayifci, Abdurrahman
    Safali, Mukerrem
    Ilgan, Seyfettin
    Bagci, Sait
    [J]. JOURNAL OF DIGESTIVE DISEASES, 2007, 8 (04) : 211 - 215
12345